BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25301083)

  • 1. CUB domain containing protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells.
    Orchard-Webb DJ; Lee TC; Cook GP; Blair GE
    BMC Cancer; 2014 Oct; 14():754. PubMed ID: 25301083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma.
    Uekita T; Tanaka M; Takigahira M; Miyazawa Y; Nakanishi Y; Kanai Y; Yanagihara K; Sakai R
    Am J Pathol; 2008 Jun; 172(6):1729-39. PubMed ID: 18467693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.
    Law ME; Ferreira RB; Davis BJ; Higgins PJ; Kim JS; Castellano RK; Chen S; Luesch H; Law BK
    Breast Cancer Res; 2016 Aug; 18(1):80. PubMed ID: 27495374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.
    Casar B; Rimann I; Kato H; Shattil SJ; Quigley JP; Deryugina EI
    Oncogene; 2014 Jan; 33(2):255-68. PubMed ID: 23208492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
    Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
    Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.
    Park JJ; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
    BMC Cancer; 2012 Mar; 12():81. PubMed ID: 22390300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratum basale keratinocyte expression of the cell-surface glycoprotein CDCP1 during epidermogenesis and its role in keratinocyte migration.
    McGovern JA; Heinemann JR; Burke LJ; Dawson R; Parker TJ; Upton Z; Hooper JD; Manton KJ
    Br J Dermatol; 2013 Mar; 168(3):496-503. PubMed ID: 23121233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.
    Benes CH; Poulogiannis G; Cantley LC; Soltoff SP
    Oncogene; 2012 Feb; 31(5):653-63. PubMed ID: 21725358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.
    Wortmann A; He Y; Christensen ME; Linn M; Lumley JW; Pollock PM; Waterhouse NJ; Hooper JD
    J Biol Chem; 2011 Dec; 286(49):42303-42315. PubMed ID: 21994943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells.
    Miura S; Hamada S; Masamune A; Satoh K; Shimosegawa T
    Exp Cell Res; 2014 Feb; 321(2):209-18. PubMed ID: 24384474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model.
    Siva AC; Wild MA; Kirkland RE; Nolan MJ; Lin B; Maruyama T; Yantiri-Wernimont F; Frederickson S; Bowdish KS; Xin H
    Cancer Res; 2008 May; 68(10):3759-66. PubMed ID: 18483259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
    Uekita T; Sakai R
    Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
    Liu H; Ong SE; Badu-Nkansah K; Schindler J; White FM; Hynes RO
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1379-84. PubMed ID: 21220330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrared spectral signatures of CDCP1-induced effects in colon carcinoma cells.
    Yousef I; Bréard J; SidAhmed-Adrar N; Maâmer-Azzabi A; Marchal C; Dumas P; Le Naour F
    Analyst; 2011 Dec; 136(24):5162-8. PubMed ID: 22034616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.
    Gandji LY; Proust R; Larue L; Gesbert F
    PLoS One; 2015; 10(4):e0123472. PubMed ID: 25876044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell surface glycoprotein CDCP1 in cancer--insights, opportunities, and challenges.
    Wortmann A; He Y; Deryugina EI; Quigley JP; Hooper JD
    IUBMB Life; 2009 Jul; 61(7):723-30. PubMed ID: 19514048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.
    Seidel J; Kunc K; Possinger K; Jehn C; Lüftner D
    Biochem Biophys Res Commun; 2011 Oct; 414(1):226-32. PubMed ID: 21945930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.
    Hooper JD; Zijlstra A; Aimes RT; Liang H; Claassen GF; Tarin D; Testa JE; Quigley JP
    Oncogene; 2003 Mar; 22(12):1783-94. PubMed ID: 12660814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.
    Kuhara K; Tokuda K; Kitagawa T; Baron B; Tokunaga M; Harada K; Terasaki M; Uehara O; Ohta T; Takai R; Hamada JI; Kobayashi M; Shimo T; Nagayasu H; Kuramitsu Y
    Anticancer Res; 2018 Nov; 38(11):6107-6111. PubMed ID: 30396925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
    Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
    Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.